BC expands biosimilars switching program to include blood thinner enoxaparin

Mar 22, 2022

The Government of British Columbia announced an expansion of its biosimilars switching program to include blood thinner enoxaparin.  This change took effect on 22 March 2022, with all new PharmaCare approvals to be for biosimilar enoxaparin only.

Print Page Mail Article